Cite
HARVARD Citation
Manns, M. et al. (n.d.). Overall safety profile of boceprevir plus peginterferon alfa‐2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials. Liver international. pp. 707-719. [Online].